Presidential Address to The American Association of Immunologists

Philippa Marrack, * Jeremy Bender, Michael Jordan, William Rees,* Jennifer Robertson,* Brian C. Schaefer, and John Kappler* Early in the 20th century, scientists realized that grafts and transplanted tumors that differed from their hosts at the MHC were rapidly rejected. Later work showed that lymphocytes were unstoppably interested in MHC differences, so much so that Jerne, in a visionary article in the first issue of the European Journal of Immunology (1), proposed that lymphocyte receptors were selected evolutionarily to react with MHC proteins. His article continued with the proposal that lymphocytes would mutate their receptors during development in the thymus, such that, once mature, they could no longer react with the MHC of their hosts, but would retain the ability to react with other MHC alleles of their species. Jerne’s ideas have been modified as our understanding of thymocyte development has increased. For example, it is now known that T cells rarely, if ever, mutate their a andb TCR genes (2, 3). Also, it is now recognized that thymocytes are selected in two ways for the reactivity of their TCRs, by positive selection for TCRs that react with self-MHC plus self-peptides with low but appreciable affinity (4–9), and by deletion if their TCRs react too well with self-MHC plus self-peptides (10–12). Despite the modifications to Jerne’s hypothesis, which were forced by these findings, immunologists clung to the idea that MHC proteins and theaandb-chains of TCRs must coevolve to have some affinity for each other. There is quite a lot of evidence for the notion.abTCR T cells do react with appreciable fre quency in the absence of priming with foreign MHC proteins (13– 16). The frequency of allo-MHC-reactive T cells in the unprimed population is much higher than for any other Ag except the superantigens. Such a high alloreactivity could be because of an evolutionarily conserved fit between TCRs and MHC. On the other hand, the germline repertoire of ab TCRs may actually be completely random and the high frequency with which TCRs react with MHC may be because of the fact that allogeneic MHC proteins, with the many host-derived peptides to which they are bound, actually comprise thousands of Ags, not one (17), an idea that is supported by the fact that many alloreactive T cells recognize both the allogeneic MHC protein and the peptide bound to it (18). Alternatively, high frequency reaction with foreign MHC may simply be because of positive selection in the thymus for low reaction with self-MHC (plus peptides) and heteroclitic cross reaction between self and foreign MHC. To deal with the complication that positive selection almost certainly biases the repertoire of ab TCRs toward MHC reaction, several groups have tested the allo-MHC reactivity of TCRs from thymocytes that have not been positively and negatively selected or that have been formed by random combinations of TCR aand b-chains (19, 20). The experiments suggested that the unselected abTCR repertoire had some intrinsic affinity for MHC. However, *Howard Hughes Medical Institute, Department of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, and Departments ofPharmacology, Biochemistry and Molecular Genetics, and Medicine, University of Colorado Health Sciences Center, Denver, CO 80206

[1]  R. Atkins,et al.  Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of the frequency of donor lymphocytes which respond to each Ag-B-determined antigenic complex , 1975, The Journal of experimental medicine.

[2]  M. Bevan,et al.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? , 1977, Cellular immunology.

[3]  P. Fink,et al.  The Influence of Thymus H‐2 Antigens on the Specificity of Maturing Killer and Helper Cells , 1978, Immunological reviews.

[4]  R. Zinkernagel,et al.  On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? , 1978, The Journal of experimental medicine.

[5]  L. Sherman Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes , 1982, The Journal of experimental medicine.

[6]  L. Hood,et al.  The murine T-cell receptor uses a limited repertoire of expressed Vβ gene segments , 1985, Nature.

[7]  J. Yagüe,et al.  The T cell repertoire may be biased in favor of MHC recognition , 1986, Cell.

[8]  P. Marrack,et al.  T cell tolerance by clonal elimination in the thymus , 1987, Cell.

[9]  J. Sprent,et al.  T Cell Selection in the Thymus , 1988, Immunological reviews.

[10]  R. Zinkernagel,et al.  Positive selection of CD4+ thymocytes controlled by MHC class II gene products , 1988, Nature.

[11]  H. Boehmer,et al.  Positive selection of antigen-specific T cells in thymus by restricting MHC molecules , 1988, Nature.

[12]  A. Heimberger,et al.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. , 1990, Science.

[13]  J. Bluestone,et al.  Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition , 1992, The Journal of experimental medicine.

[14]  J. D. Dal Porto,et al.  Major histocompatibility complex conformational epitopes are peptide specific , 1992, The Journal of experimental medicine.

[15]  M. Davis,et al.  Analysis of a T cell receptor gene as a target of the somatic hypermutation mechanism , 1992, The Journal of experimental medicine.

[16]  L. Sherman,et al.  The molecular basis of allorecognition. , 1993, Annual review of immunology.

[17]  P. Ohashi,et al.  Positive and negative thymocyte selection induced by different concentrations of a single peptide. , 1994, Science.

[18]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[19]  L. Pease,et al.  Peptide-induced conformational changes in class I molecules. Direct detection by flow cytometry. , 1994, Journal of immunology.

[20]  S. Tonegawa,et al.  Evidence for a differential avidity model of T cell selection in the thymus , 1994, Cell.

[21]  A. Lobashevsky,et al.  Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles. , 1996, Transplantation.

[22]  D. Fremont,et al.  Structures of an MHC Class II Molecule with Covalently Bound Single Peptides , 1996, Science.

[23]  Robyn L. Stanfield,et al.  An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex , 1996, Science.

[24]  P. Marrack,et al.  The Repertoire of T Cells Shaped by a Single MHC/Peptide Ligand , 1996, Cell.

[25]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.

[26]  Mark I. Greene,et al.  Control of MHC Restriction by TCR Vα CDR1 and CDR2 , 1996, Science.

[27]  P. Marrack,et al.  T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. , 1997, Immunity.

[28]  L R Pease,et al.  Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Zerrahn,et al.  The MHC Reactivity of the T Cell Repertoire Prior to Positive and Negative Selection , 1997, Cell.

[30]  D. Wiley,et al.  Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. , 1998, Immunity.

[31]  W A Hendrickson,et al.  Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. , 1998, Immunity.

[32]  N. Gascoigne,et al.  Polymorphism within a TCRAV family influences the repertoire through class I/II restriction. , 1998, Journal of immunology.

[33]  P. A. Peterson,et al.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.

[34]  A. Rudensky,et al.  Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  I. Wilson Perspectives: protein structure. Class-conscious TCR? , 1999, Science.

[36]  P. Marrack,et al.  An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Smolyar,et al.  The crystal structure of a T cell receptor in complex with peptide and MHC class II. , 1999, Science.

[38]  B M Baker,et al.  Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. , 1999, Immunity.

[39]  E. Unanue,et al.  Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. , 2000, Immunity.

[40]  K. Garcia,et al.  A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. , 2000, Science.

[41]  D. Wiley,et al.  Structure of a covalently stabilized complex of a human αβ T‐cell receptor, influenza HA peptide and MHC class II molecule, HLA‐DR1 , 2000, The EMBO journal.

[42]  E. Palmer,et al.  Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question1 , 2001, The Journal of Immunology.

[43]  E. Joly,et al.  Genetic control of peripheral TCRAV usage by representation in the preselection repertoire and MHC allele-specific overselection. , 2001, International immunology.